ARCH Venture Management, LLC
CIK: 0001274403SEC EDGAR →
Portfolio Value
$651.7M
Holdings
9
As of
Q4 2025
New Positions
0
Closed Positions
2
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | MAZE THERAPEUTICS INC. | 4,120,053 | $170.7M | 26.19% |
| 2 | BEAM THERAPEUTICS INC. | 4,540,132 | $125.9M | 19.31% |
| 3 | RAPPORT THERAPEUTICS INC. | 3,728,738 | $113.1M | 17.36% |
| 4 | LYELL IMMUNOPHARMA INC. | 2,759,072 | $84.9M | 13.03% |
| 5 | VIR BIOTECHNOLOGY INC. | 12,916,663 | $77.9M | 11.95% |
| 6 | ERASCA INC. | 11,055,554 | $41.1M | 6.31% |
| 7 | GOSSAMER BIO INC. | 8,055,916 | $25.0M | 3.83% |
| 8 | 10X GENOMICS INC. | 737,539 | $12.0M | 1.85% |
| 9 | Q32 BIO INC. | 320,482 | $1.1M | 0.16% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 9 | $651.7M | 100.0% |